BioSpace News Archive

Policy

Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies

In July 2022, Ablaze Pharma and Wenjiang District Government of Chengdu jointly signed the strategic agreement during the Conference of Major Advanced Manufacturing Projects by Foreign Direct Investment.

August 2, 2022
·
3 min read
Business

Geno Hires First Chief Legal Officer on Path to Accelerate the Transition to More Sustainable Materials

Sustainability leader Genomatica welcomes its first chief legal officer Shawnte Mitchell to help fuel the company’s rapid growth.

August 2, 2022
·
3 min read
Business

CURE Pharmaceutical Announces the Appointment of New Board Member

CURE Pharmaceutical Holding Corp., a proprietary platform technology company, announced the appointment of Gerald Bagg to its board of directors.

August 2, 2022
·
5 min read
Business

Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced the appointment of Sam Ropp, Ph.D., as Chief Commercial Officer.

August 2, 2022
·
5 min read
KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference

KemPharm, Inc. today announced that Richard W. Pascoe, Executive Chairman of KemPharm, will present at the Canaccord Genuity 42nd Annual Growth Conference being held August 8-11, 2022.

August 2, 2022
·
1 min read
Appili Therapeutics to Present at WorldLeish7 Conference in Cartagena, Columbia

Appili Therapeutics Inc. today announced that Armand Balboni, M.D, Ph.D, Chief Medical Officer of Appili, will participate at the seventh iteration of WorldLeish, from August 1 to 6 2022, and present an update on Appili program ATI-1801.

August 2, 2022
·
5 min read
Business

BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022

BioAtla, Inc. today announced that it plans to host a conference call and webcast on Tuesday, August 9, 2022 at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2022 and provide business highlights.

August 2, 2022
·
2 min read
Biotech Bay

Pliant Therapeutics to Participate in BTIG Biotechnology Conference

Pliant Therapeutics, Inc. today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, will participate in a panel discussion at the BTIG Biotechnology Conference 2022.

August 2, 2022
·
1 min read
Biotech Bay

Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference

Day One Biopharmaceuticals announced that management will participate in a panel discussion at the 2022 Wedbush PacGrow Healthcare Virtual Conference.

August 2, 2022
·
1 min read
Business

VBL Therapeutics Announces Workforce Reduction

VBL Therapeutics, a biotechnology company developing targeted medicines for cancer and immune-inflammatory diseases, announced an organizational streamlining designed to reduce operating expenses and preserve capital.

August 2, 2022
·
3 min read